L2IV34 Stock Overview
A medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
LivaNova PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$36.22 |
| 52 Week High | US$40.62 |
| 52 Week Low | US$29.88 |
| Beta | 1.01 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -7.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| L2IV34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | -0.6% |
| 1Y | n/a | 10.5% | -7.3% |
Return vs Industry: Insufficient data to determine how L2IV34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how L2IV34 performed against the BR Market.
Price Volatility
| L2IV34 volatility | |
|---|---|
| L2IV34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in BR Market | 9.7% |
| 10% least volatile stocks in BR Market | 3.2% |
Stable Share Price: L2IV34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine L2IV34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 2,900 | Vladimir Makatsaria | www.livanova.com |
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
LivaNova PLC Fundamentals Summary
| L2IV34 fundamental statistics | |
|---|---|
| Market cap | R$15.01b |
| Earnings (TTM) | R$136.43m |
| Revenue (TTM) | R$7.15b |
110.0x
P/E Ratio2.1x
P/S RatioIs L2IV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L2IV34 income statement (TTM) | |
|---|---|
| Revenue | US$1.24b |
| Cost of Revenue | US$396.25m |
| Gross Profit | US$845.49m |
| Other Expenses | US$821.80m |
| Earnings | US$23.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 68.09% |
| Net Profit Margin | 1.91% |
| Debt/Equity Ratio | 47.8% |
How did L2IV34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 14:43 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LivaNova PLC is covered by 30 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| Michael Polark | Baird |
| Matt Miksic | Barclays |